Real-world data (RWD) is transforming clinical research, augmenting existing randomized controlled trial (RCT) data to de-risk studies and improve generalizability. With regulators setting clearer ...
Davos panel weighs AI’s healthcare promise against regulation, bias, and need for causal, brain-inspired models.
IIT Guwahati researchers identify 493 high-risk sites for future glacial lakes in the Eastern Himalayas to enhance disaster ...
A new study has demonstrated how networks of spiking nanolasers could emulate a key principle of brain function: to imagine ...
Leaders across research, clinical care, industry, and patient advocacy convene to accelerate rare disease breakthroughs from discovery to real-world patient impact NORWELL, Mass., Feb. 5, 2026 ...
Chris Petrillo, Principal Product Manager at Wikimedia Enterprise, talked about AI bots, human editors and the convergence of ...
LCGC International salutes Jack Henion and Bob W.J. Pirok, winners of the 19th annual LCGC Lifetime Achievement and Emerging ...
Waiting for alerts is obsolete — predictive engineering lets cloud systems see trouble coming and fix it before users ever ...
Duloxetine 120 mg offers the greatest economic value for treating moderate-to-severe fibromyalgia, followed by pregabalin 450 ...
Whether a smartphone battery lasts longer or a new drug can be developed to treat incurable diseases depends on how stably the atoms constituting the material are bonded. The core of molecular design ...
On a clear night, the Milky Way and the Andromeda galaxy look like close neighbors. In space, they really are.
The National Organization for Rare Disorders (NORD®) today announced the agenda for its second annual NORD® Rare Disease Scientific Symposium, taking place April 14?15, 2026, in Arlington, Va., and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results